Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
Silvia Scoccianti, Lorenzo Livi(European Society for Sexual Medicine), Francesco Pasqualetti, Vieri Scotti(University of Florence), Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Ernesto Maranzano(University of Perugia), Davide Franceschini(IRCCS Humanitas Research Hospital), Paolo Muto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), M. Trignani(Ospedale SS. Annunziata), G. Beltramo(Centro Diagnostico Italiano), Laura Fariselli(University of Turin), Paolo Tini(University of Siena), Emilia Giudice(Policlinico Tor Vergata), Pierina Navarria(IRCCS Humanitas Research Hospital), Valentina Pinzi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Rossella Di Franco(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessio Bruni(University of Modena and Reggio Emilia), Emanuela Olmetto(Azienda Ospedaliero-Universitaria Careggi), Isacco Desideri(Azienda Ospedaliero-Universitaria Careggi), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Marco Krengli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mattia Falchetto Osti(Azienda Ospedaliera Sant'Andrea), Niccolò Giaj‐Levra(Ospedale Sacro Cuore Don Calabria), Saverio Caini, Guido Pecchioli(Azienda Ospedaliero-Universitaria Careggi), Paolo Matteucci(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Anna Merlotti(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Paola Anselmo(Santa Maria Nuova Hospital), Cristina Mantovani, Sara Pedretti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)
Cited by 91
Related Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
|Journal of Clinical Oncology|2012|645